Cite
HARVARD Citation
López-Torres, M. et al. (2021). 16α-Bromoepiandrosterone as a new candidate for experimental diabetes–tuberculosis co-morbidity treatment. Clinical and experimental immunology. pp. 232-245. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
López-Torres, M. et al. (2021). 16α-Bromoepiandrosterone as a new candidate for experimental diabetes–tuberculosis co-morbidity treatment. Clinical and experimental immunology. pp. 232-245. [Online].